These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 9578088)
1. Fas ligand expression in nodal non-Hodgkin's lymphoma. Müllauer L; Mosberger I; Chott A Mod Pathol; 1998 Apr; 11(4):369-75. PubMed ID: 9578088 [TBL] [Abstract][Full Text] [Related]
2. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease. Nguyen PL; Harris NL; Ritz J; Robertson MJ Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139 [TBL] [Abstract][Full Text] [Related]
3. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas. Drillenburg P; van der Voort R; Koopman G; Dragosics B; van Krieken JH; Kluin P; Meenan J; Lazarovits AI; Radaszkiewicz T; Pals ST Am J Pathol; 1997 Mar; 150(3):919-27. PubMed ID: 9060830 [TBL] [Abstract][Full Text] [Related]
4. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation. Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease. Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677 [TBL] [Abstract][Full Text] [Related]
6. Clusterin expression in malignant lymphomas: a survey of 266 cases. Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802 [TBL] [Abstract][Full Text] [Related]
7. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation. Felgar RE; Macon WR; Kinney MC; Roberts S; Pasha T; Salhany KE Am J Pathol; 1997 Jun; 150(6):1893-900. PubMed ID: 9176382 [TBL] [Abstract][Full Text] [Related]
8. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells? Bodey B; Bodey B; Siegel SE; Kaiser HE In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378 [TBL] [Abstract][Full Text] [Related]
9. [Paraneoplastic lymphadenopathy]. Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471 [TBL] [Abstract][Full Text] [Related]
10. Immunophenotypic analysis of extranodal non-Hodgkin's lymphomas in the oral cavity. Takahashi H; Fujita S; Okabe H; Tsuda N; Tezuka F Pathol Res Pract; 1993 Apr; 189(3):300-11. PubMed ID: 8332573 [TBL] [Abstract][Full Text] [Related]
11. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint]. Meusers P; Brittinger G Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections. Dorfman DM; Shahsafaei A Mod Pathol; 1997 Sep; 10(9):859-63. PubMed ID: 9310947 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study. Leong IT; Fernandes BJ; Mock D Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266 [TBL] [Abstract][Full Text] [Related]
15. [The results of histological and immunohistological studies of primary biopsies in 400 patients with non-Hodgkin's lymphoma in the North-West region of Russia (according to WHO classification)]. Krivolapov IuA Ter Arkh; 2004; 76(7):64-70. PubMed ID: 15379131 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical studies of protein kinase D (PKD) 2 expression in malignant human lymphomas. Kovalevska LM; Yurchenko OV; Shlapatska LM; Berdova GG; Mikhalap SV; Van Lint J; Sidorenko SP Exp Oncol; 2006 Sep; 28(3):225-30. PubMed ID: 17080017 [TBL] [Abstract][Full Text] [Related]
17. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases. Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346 [TBL] [Abstract][Full Text] [Related]
18. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively. Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597 [TBL] [Abstract][Full Text] [Related]
19. Expression of Fas and Fas ligand in cutaneous B-cell lymphomas. Zoi-Toli O; Meijer CJ; Oudejans JJ; de Vries E; van Beek P; Willemze R J Pathol; 1999 Dec; 189(4):533-8. PubMed ID: 10629554 [TBL] [Abstract][Full Text] [Related]